Becker's Healthcare October 31, 2023
Alexis Kayser

Bosses can boomerang too — but that doesn’t mean they should, Bloomberg reported Oct. 26.

The publication analyzed data from six publicly traded companies that “boomeranged,” or reappointed successful past CEOs over the last three years. Analysts found that although a former leader’s return can steady or even temporarily raise stocks in the short term, these CEOs are unlikely to renew lost gains over time. Collectively, the six companies — Dollar General, Walt Disney Co., Starbucks, DuPont de Nemours, Bausch & Lomb and Stitch Fix — lost $88 billion in market value in the six months before their reappointment announcements and had only recovered $10 billion...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Employer
CVS Caremark taps Omada on GLP-1 program
JPMorgan’s Health Unit To Invest In Small Business Health Plans
Measles Defense 101: The Significance of Employee Immunization Tracking
Employer-Provider Direct Contracting: Practice And Policy
Why businesses judge AI like humans — and what that means for adoption

Share This Article